Shikonin inhibits myeloid differentiation protein 2 to prevent LPS‐induced acute lung injury

Abstract

Our studies have uncovered the mechanism underlying the biological activity of shikonin in ALI and suggest that the targeting of MD2 may prove to be beneficial as a treatment option for this condition.